Concepedia

Τushar Garimella

ΤG

Statistics

Publications

16

Citations

1.5K

H-Index

14

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Daiichi Sankyo (United States)

University of Maryland, Baltimore

Certara (United States)

Abbott (United Kingdom)

Τushar Garimella is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

2003–2023

16

Publications

16

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl et al. · The Lancet · 2010 · 690 citations

, , +16

Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy

Donald E. Kohan, Yili Pritchett, Mark E. Molitch et al. · Journal of the American Society of Nephrology · 2011 · 235 citations · Full text

, , +17

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<scp>d</scp>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Judith E. Karp, Antonino Passaniti, Ivana Gojo et al. · Clinical Cancer Research · 2005 · 78 citations

, , +16

Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2‐Positive Breast Cancer and Other Solid Tumors

Ophelia Yin, Yuan Xiong, Seiko Endo et al. · Clinical Pharmacology & Therapeutics · 2020 · 60 citations · Full text

, , +17

Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition

Hong Shen, Lisa J. Christopher, Yurong Lai et al. · Drug Metabolism and Disposition · 2018 · 56 citations · Full text

, , +12

1–5 of 16